6. Technical approaches

PCI versus Optimal medical therapy for CTO

EURO CTO 3 years
Objective
to compare the 3-year adverse clinical outcomes of PCI plus optimal medical treatment (OMT) compared to OMT alone for treatment of chronic total occlusion
Study
multicentre, randomised (2:1) controlled trial
Population
at least 1 CTO; if MVD-non-CTO lesions were first treated before randomisation
Endpoints
cardiovascular death or non-fatal MI at 3 years
Conclusion
among patients with chronic total occlusion there was no difference in the 3-year incidence of cardiovascular death or myocardial infarction between PCI plus OMT and OMT alone
Werner et al. EuroIntervention 2023; 19: online July
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved